Biotech

All Articles

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease medicine

.AstraZeneca has settled CSPC Pharmaceutical Group $one hundred million for a preclinical heart dise...

Zephyrm finds Hong Kong IPO to fund period 3 cell treatment tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, declaring (PDF) for an IPO to st...

Frazier Lifestyle Sciences gathers $630M for tiny, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an even more $630 million for its own fund focu...

GigaGen gets up to $135M BARDA dollars to beat botox

.Antitoxin connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up it...

GPCR agency Septerna files for IPO on strength of preclinical records

.Septerna will figure out how a biotech without "any type of purposeful medical data" fares in the l...

Kurma finalizes initially $154M haul for largest biotech fund as yet

.International VC organization Kurma Partners has revealed its own most up-to-date biotech fund, alo...

Prothena advertises one exec while an additional leaves-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings and r...

Editas capitalize Tip Cas9 licensing liberties for $57M

.Versus the backdrop of a Cas9 patent battle that declines to pass away, Editas Medicine is moneying...

Ultragenyx modifies gene therapy application to dial up efficiency

.A minority of clients taking Ultragenyx Drug's Wilson condition gene therapy UX701 have actually go...

Biopharma cutback cost stabilizes in Q3: Brutal Biotech analysis

.As summer months heat energy relies on cool down winds, really hopes that this year would certainly...